The American Medical Association (AMA) provided ammunition today to regulators, policymakers and legislators concerned about just what role pharmacy benefit managers play in the drug supply chain.An AMA paper (PDF) argues that vertical and horizontal PBM consolidation leads to a decline in price competition that hurts insurers—at least those who don’t own, or are owned […]